MESA LABS DECLARES QUARTERLY DIVIDEND
03 October 2024 - 4:00AM
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or
the “Company”) today announced that its Board of Directors has
declared a regular quarterly dividend of $0.16 per share of common
stock. The dividend will be payable on December 16, 2024, to
shareholders of record at the close of business on November 29,
2024.
About Mesa Laboratories, Inc.
Mesa is a global leader in the design and
manufacture of life science tools and critical quality control
solutions for regulated applications in the pharmaceutical,
healthcare and medical device industries. Mesa offers products and
services to help our customers ensure product integrity, increase
patient and worker safety, and improve the quality of life
throughout the world.
Forward Looking Statements
This press release may contain information that
constitutes forward-looking statements. Forward-looking statements
are subject to risks and uncertainties that could cause actual
results to differ materially from our historical experience and
present expectations or projections. Forward-looking
statements include statements relating to revenues and growth,
operating results, profit margin pressure, industry conditions,
economic conditions, demand, competition, the effects of additional
actions taken to become more efficient or lower costs, risks
related to the integration of acquired businesses, changes in legal
and regulatory matters, the ability to generate additional cash
flow, and any events or developments that we expect or anticipate
will occur in the future. Generally, the words “expect,”
“anticipate,” “seek,” “intend,” “plan,” “believe,” “could,”
“estimate,” “may,” “target,” “project,” and similar expressions
identify forward-looking statements. However, the absence of these
words or similar expressions does not mean that a statement is not
forward-looking. These statements are based upon current
information and expectations. Actual results may differ materially
from those estimated or anticipated as a result of these risks and
unknowns or other risks and uncertainties. For additional
information concerning these and other risks and uncertainties that
could affect these statements, and our business, see our Annual
Report on Form 10-K for the year ended March 31, 2024, as well as
other risks and uncertainties detailed from time to time in our
reports on Forms 10-Q and 8-K subsequently filed with the
Securities and Exchange Commission. Readers are cautioned not to
place undue reliance on these forward-looking statements, which
speak only as of the date hereof. We undertake no obligation to
republish revised forward-looking statements to reflect events or
circumstances after the date hereof, to provide any updates, or to
reflect the occurrence of future events.
CONTACT: Gary Owens; President and CEO, or John Sakys; CFO, both of Mesa Laboratories, Inc., +1-303-987-8000
For more information about the Company, please visit its website at www.mesalabs.com
Mesa Laboratories (NASDAQ:MLAB)
Historical Stock Chart
From Nov 2024 to Dec 2024
Mesa Laboratories (NASDAQ:MLAB)
Historical Stock Chart
From Dec 2023 to Dec 2024